- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Actinogen Medical Ltd (ACW)
Assess today's live Actinogen Medical Ltd (ACW) share price, performance and insights using our live Sydney: ACW stock exchange data.
Analyse the historical data and Actinogen Medical Ltd share price performance charts on this page. Our technical summary section provides analysis on Actinogen Medical share price buy/sell indicators using real-time data (or discuss the Actinogen Medical (ACW) stock price today with other investors in the Actinogen Medical ASX share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current ASX ACW share price (ISIN: AU000000ACW3) to enhance your trading decisions with our free investment tools and resources.
What Is the Actinogen Medical Ltd Share Price Today?
The Actinogen Medical share price today is 0.038.
What Is the Stock Symbol for Actinogen Medical Ltd
The stock symbol (or 'ticker') for Actinogen Medical Ltd is "ACW."
What Stock Exchange Does Actinogen Medical Ltd Trade On?
Actinogen Medical Ltd is listed and trades on the Sydney stock exchange.
Is Actinogen Medical Ltd a Good Stock to Buy?
Determining whether Actinogen Medical Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Actinogen Medical Ltd share price performance charts on this page. Our technical summary section provides analysis on Actinogen Medical share price buy/sell indicators using real-time data (or discuss the Actinogen Medical (ACW) stock price today with other investors in the Actinogen Medical ASX share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current ASX ACW share price (ISIN: AU000000ACW3) to enhance your trading decisions with our free investment tools and resources.
What Is the Actinogen Medical Ltd Share Price Today?
The Actinogen Medical share price today is 0.038.
What Is the Stock Symbol for Actinogen Medical Ltd
The stock symbol (or 'ticker') for Actinogen Medical Ltd is "ACW."
What Stock Exchange Does Actinogen Medical Ltd Trade On?
Actinogen Medical Ltd is listed and trades on the Sydney stock exchange.
Is Actinogen Medical Ltd a Good Stock to Buy?
Determining whether Actinogen Medical Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Sydney
Currency in AUD
0.038
+0.003(+8.57%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.036
0.039
52 wk Range
0.019
0.072
Earnings results expected in 11 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0360.039
52 wk Range
0.0190.072
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
ACW Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
0.080
Upside
+110.53%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 0.080
(+110.53% Upside)
Earnings
Latest Release
25/02/2026
EPS / Forecast
-- / --
Revenue / Forecast
1.87M / --
Compare ACW to Peers and Sector
Metrics to compare | ACW | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipACWPeersSector | |
|---|---|---|---|---|
P/E Ratio | −7.6x | −6.7x | −0.5x | |
PEG Ratio | 0.13 | −0.05 | 0.00 | |
Price/Book | 16.3x | 4.5x | 2.6x | |
Price / LTM Sales | 18.5x | 17.7x | 3.1x | |
Upside (Analyst Target) | 128.6% | 129.5% | 53.0% | |
Fair Value Upside | Unlock | 3.0% | 6.3% | Unlock |
Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It develops Xanamem, an oral medication and inhibitor of the 11ß-HSD1 enzyme that achieves target engagement in the brain for the treatment of Alzheimer’s disease, major depressive disorder, fragile x syndrome, and other neurological diseases. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.
Ownership
Ownership Overview
FAQ
What Is the Actinogen Medical (Sydney: ACW) Share Price Today?
The Actinogen Medical stock price today is 0.038 AUD.
What Stock Exchange Does Actinogen Medical (ACW) Trade On?
Actinogen Medical is listed and trades on the Sydney Stock Exchange.
What Is the Ticker (Stock Symbol) for Actinogen Medical?
The stock symbol (also called a 'ticker') for Actinogen Medical is "ACW."
What Is the Current Actinogen Medical Market Capitalisation?
As of today, Actinogen Medical (Sydney: ACW) market cap is 136.470M AUD.
What Is Actinogen Medical's (ACW) Earnings Per Share (TTM)?
The Actinogen Medical EPS is currently -0.006 (Trailing Twelve Months).
When Is the Next Actinogen Medical Earnings Date?
Actinogen Medical's next earnings report will be released on 03/06/2026.
Is ACW a Buy or Sell From a Technical Analyst Perspective?
Based on today's Actinogen Medical moving averages and other technical indicators, the daily buy/sell signal for ACW stock is Strong Sell.
How Many Times Has Actinogen Medical Stock Split?
Actinogen Medical has split 4 times. (See the ACW stock split history page for full effective split date and price information.)
How Many Employees Does Actinogen Medical Have?
Actinogen Medical has 6 employees, based on their latest Companies House report.
What is the current trading status of Actinogen Medical (Sydney: ACW)?
As of 23/05/2026, Actinogen Medical (ACW) is trading at a share price of 0.038 AUD, with a previous close of 0.035 AUD. The stock has fluctuated within a day range of 0.036 AUD to 0.039 AUD, while its 52-week range spans from 0.019 AUD to 0.072 AUD.
What Is Actinogen Medical (ACW) Price Target According to Analysts?
The average 12-month price target for Actinogen Medical is 0.080 AUD, with a high estimate of 0.08 AUD and a low estimate of 0.08 AUD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +110.53% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.